# BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
> **ANDA091086** · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 2022-10-31
## Drug
- **FDA Application Number:** ANDA091086
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- **Generic name:** Brimonidine Tartrate
- **Active ingredients:** BRIMONIDINE TARTRATE; TIMOLOL MALEATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** SENTISS
- **First approval:** 2022-10-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091086)
---
*AI Analytics · CC0 1.0*